Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 14 (Search time: 0.001 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2014Clinical epidemiology and predictors of outcome in children hospitalised with influenza A(H1N1)pdm09 in 2009: a prospective national studyKhandaker, G.; Zurynski, Y.; Ridley, G.; Buttery, J.; Marshall, H.; Richmond, P.; Royle, J.; Gold, M.; Walls, T.; Whitehead, B.; McIntyre, P.; Wood, N.; Booy, R.; Elliott, E.
2015Febrile seizures following measles and varicella vaccines in young children in AustraliaMacartney, K.; Gidding, H.; Trinh, L.; Wang, H.; McRae, J.; Crawford, N.; Gold, M.; Kynaston, A.; Blyth, C.; Yvonne, Z.; Elliott, E.; Booy, R.; Buttery, J.; Marshall, H.; Nissen, M.; Richmond, P.; McInytre, P.; Wood, N.
2010Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: A randomized trialNolan, T.; McVernon, J.; Skeljo, M.; Richmond, P.; Wadia, U.; Lambert, S.; Nissen, M.; Marshall, H.; Booy, R.; Heron, L.; Hartel, G.; Lai, M.; Basser, R.; Gittleson, C.; Greenberg, M.
2015Five-year antibody persistence and safety after a single dose of combined Haemophilus influenzae Type B Neisseria meningitidis Serogroup C-tetanus toxoid conjugate vaccine in Haemophilus influenzae Type B-primed toddlersBooy, R.; Nolan, T.; Reynolds, G.; Richmond, P.; Nissen, M.; Marshall, H.; Stoney, T.; Van Der Wielen, M.; Kolhe, D.; Miller, J.
2013Safety and tolerability of a 2009 trivalent inactivated split-virion influenza vaccine in infants, children and adolescentsLambert, S.; Chuk, L.; Nissen, M.; Nolan, T.; McVernon, J.; Booy, R.; Heron, L.; Richmond, P.; Walls, T.; Marshall, H.; Reynolds, G.; Hartel, G.; Hu, W.; Lai, M.
2015Group A streptococcal carriage and seroepidemiology in children up to 10 years of age in AustraliaMarshall, H.; Richmond, P.; Nissen, M.; Lambert, S.; Booy, R.; Reynolds, G.; Sebastian, S.; Pride, M.; Jansen, K.; Anderson, A.; Scully, I.
2013Changes in patterns of hospitalized children with varicella and of associated varicella genotypes after introduction of varicella vaccine in AustraliaMarshall, H.; McIntyre, P.; Richmond, P.; Buttery, J.; Royle, J.; Gold, M.; Wood, N.; Elliott, E.; Zurynski, Y.; Toi, C.; Dwyer, D.; Booy, R.
2011Immediate and longer term immunogenicity of a single dose of the combined haemophilus influenzae type B-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in primed toddlers 12 to 18 months of ageBooy, R.; Richmond, P.; Nolan, T.; McVernon, J.; Marshall, H.; Nissen, M.; Reynolds, G.; Ziegler, J.; Heron, L.; Lambert, S.; Caubet, M.; Mesaros, N.; Boutriau, D.
2013Three-year antibody persistence and safety after a single dose of combined haemophilus influenzae type b (Hib)-Neisseria meningitidis Serogroup C-tetanus toxoid conjugate vaccine in hib-primed toddlersBooy, R.; Richmond, P.; Nolan, T.; McVernon, J.; Marshall, H.; Nissen, M.; Reynolds, G.; Ziegler, J.; Stoney, T.; Heron, L.; Lambert, S.; Mesaros, N.; Peddiraju, K.; Miller, J.
2012Nosocomial vs community-acquired pandemic influenza A (H1N1) 2009: a nested case-control studyKhandaker, G.; Rashid, H.; Zurynski, Y.; Richmond, P.; Buttery, J.; Marshall, H.; Gold, M.; Walls, T.; Whitehead, B.; Elliott, E.; Booy, R.